Crook T, Ludwig R L, Marston N J, Willkomm D, Vousden K H
Institute of Cancer Research, Haddow Laboratories, Sutton, United Kingdom.
Virology. 1996 Mar 1;217(1):285-92. doi: 10.1006/viro.1996.0115.
The activity of the p53 tumor suppressor protein is regulated, at least in part, through the stability of the protein. p53 degradation in normal cells is controlled by ubiquitin-dependent proteolysis, and activation of p53 following DNA damage is associated with an increase in the stability of the protein. The human papillomavirus-encoded E6 protein abrogates p53 function by targeting it for rapid degradation, also through the ubiquitin pathway. Although the p53 protein is ubiquitinated following interaction with E6, we show here that none of the lysine residues within p53 are specifically required for E6-targeted degradation. Mutation of lysine residues within the C-terminus of p53 resulted in resistance to E6-mediated degradation in vitro, although the ability of the two proteins to form a complex was not affected. The same mutant was efficiently targeted for degradation in cells, however, illustrating a lack of correlation between the in vitro and the in vivo assays.
p53肿瘤抑制蛋白的活性至少部分是通过该蛋白的稳定性来调节的。正常细胞中p53的降解由泛素依赖性蛋白水解控制,DNA损伤后p53的激活与该蛋白稳定性的增加有关。人乳头瘤病毒编码的E6蛋白也通过泛素途径将p53靶向快速降解,从而消除p53的功能。尽管p53蛋白在与E6相互作用后会被泛素化,但我们在此表明,p53内的赖氨酸残基均不是E6靶向降解所特别需要的。p53 C末端的赖氨酸残基发生突变,导致其在体外对E6介导的降解产生抗性,尽管这两种蛋白形成复合物的能力未受影响。然而,相同的突变体在细胞中被有效靶向降解,这说明体外试验和体内试验之间缺乏相关性。